Processa Pharmaceuticals

PCSA · NASDAQ

$1.79+$0.06 (+3.47%)TodayMarket closed ·
Prev close $1.73

Who owns PCSA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 21.7% of PCSA’s shares.

  • HX Entertainment Ltd9.1%
  • Soleus Capital Management, L.P.4.8%
  • Connective Capital Management, LLC2.5%
  • Stonepine Capital Management, LLC1.6%
  • Next 6 largest institutions3.6%
  • All other shareholders78.3%
Top institutional holders of PCSA
HolderShares% of shares
HX Entertainment Ltd305.64K9.12%
Soleus Capital Management, L.P.160.94K4.80%
Connective Capital Management, LLC85.27K2.55%
Stonepine Capital Management, LLC55.00K1.64%
Young (David)22.49K0.67%
Geode Capital Management, L.L.C.22.09K0.66%
Ng (George K)21.38K0.64%
Citadel Advisors LLC21.31K0.64%
Skibsted (Russell L)16.69K0.50%
Lin (Patrick)15.72K0.47%

Largest mutual fund holders

Top mutual fund holders of PCSA
HolderShares% of shares
Fidelity Extended Market Index Fund14.22K0.42%
Vanguard Extended Market Index Fund12.73K0.38%
Fidelity Series Total Market Index Fund2.09K0.06%
Fidelity Total Market Index Fund9690.03%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $135.44K (27 trades) of PCSA on the open market, with no sales.

Latest PCSA insider transactions
InsiderTypeSharesValue
Ng George KOption exercise1.60K—
Ng George KOption exercise1.60K—
GUJRATHI SHEILAAward12.31K—
GUJRATHI SHEILAAward70.81K—
Pannu GeraldineAward33.50K—
Ng George KAward9.38K—
Neal James RAward62.22K—
Lin PatrickAward8.45K—
Guy WendyAward9.45K—
Baluch KhosoAward33.50K—

Short interest

Settled Sep 30, 2026

Shares short
4.14K
Days to cover
1.00
% of shares outstanding
0.12%
Average daily volume
23.09K
Change since last report
−72.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.